πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 29,054 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 11701427

Diels-alder conjugation methods

REGENERON PHARMACEUTICALS, INC. Β· Granted Tue Jul 18 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 13 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11702400

Salt types, crystal forms, and preparation methods for benzopyrazole compounds as RHO kina

Medshine Discovery Inc. Β· Granted Tue Jul 18 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 13 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11702423

BRM targeting compounds and associated methods of use

Prelude Therapeutics, Incorporated Β· Granted Tue Jul 18 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 13 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11702411

Pyridine, pyrazine, and triazine compounds as allosteric SHP2 inhibitors

Revolution Medicines, Inc. Β· Granted Tue Jul 18 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 13 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11701421

Compositions and methods for stabilizing flaviviruses with improved formulations

Takeda Vaccines, Inc. Β· Granted Tue Jul 18 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 13 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11701354

Pyrazolo[3,4-b]pyrazine derivatives as SHP2 phosphatase inhibitors

Relay Therapeutics, Inc. Β· Granted Tue Jul 18 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 13 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11701361

p110-delta inhibitors treat and prevent autoimmunity while sparing the ability to mount an

The Regents of the University of Colorado Β· Granted Tue Jul 18 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 13 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11701384

Methods and compositions involving interleukin-6 receptor alpha-binding single chain varia

The Regents of the University of California Β· Granted Tue Jul 18 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 13 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11701338

Use of gTso thal in manufacturing medicament for promotion of MS-275 to cross blood-brain

Northwest Institute of Plateau Biology, Chinese Academy of Sciences Β· Granted Tue Jul 18 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 13 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11701386

Cell

AUTOLUS LIMITED Β· Granted Tue Jul 18 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 13 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11702442

Cyclic dinucleotide compounds as sting agonists

The Regents of the University of California Β· Granted Tue Jul 18 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 13 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11701331

Toxic aldehyde related diseases and treatment

Aldeyra Therapeutics, Inc. Β· Granted Tue Jul 18 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 13 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11701420

Parenteral norovirus vaccine formulations

Takeda Vaccines, Inc. Β· Granted Tue Jul 18 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 13 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11702448

Method of treating melanocortin-4 receptor-associated disorders in heterozygous carriers

RHYTHM PHARMACEUTICALS, INC. Β· Granted Tue Jul 18 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 13 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11702478

Agonistic CD40 antibodies

MAB Discovery GmbH Β· Granted Tue Jul 18 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 13 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11702701

Means and methods for staging, typing and treating a cancerous disease

UniversitΓ€t Regensburg Β· Granted Tue Jul 18 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 13 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11702656

Reprogramming of non-neuronal cells into neurons and methods and compositions to treat neu

The Regents of the University of California Β· Granted Tue Jul 18 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 13 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11702657

TRNA/pre-miRNA compositions and methods for treating hepatocellular carcinoma

The Regents of the University of California Β· Granted Tue Jul 18 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 13 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11702453

Materials and methods for inhibiting flavivirus infection

THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted Tue Jul 18 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 13 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11702461

T-cell modulatory multimeric polypeptides comprising reduced-affinity immunomodulatory pol

Cue Biopharma, Inc. Β· Granted Tue Jul 18 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 13 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11702473

Site-specific antibody-drug conjugates

ADC THERAPEUTICS SA Β· Granted Tue Jul 18 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 13 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11702477

Bi-functional chimeric proteins and uses thereof

Orionis Biosciences, Inc Β· Granted Tue Jul 18 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 13 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11702630

In vitro methods of differentiating stem cells into neurons and neurons generated using th

The Regents of the University of California Β· Granted Tue Jul 18 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 13 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11701307

Organic-inorganic composite particles, manufacturing method therefor, and cosmetic

JGC Catalysts and Chemicals Ltd. Β· Granted Tue Jul 18 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 13 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted